Project Grant K08DA061258
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$196K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a mobile health (mHealth) intervention to support postpartum individuals recovering from opioid use disorder (OUD). The $174,378 award, with a performance period from June 2025 to May 2030, will fund the iterative development and feasibility evaluation of a just-in-time adaptive intervention (JITAI) grounded in acceptance...
This federal Project Grant award of $945,397 from the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs aims to adapt and evaluate a Collaborative Care Model (CCM) for providing integrated care to pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The grant will fund a two-phase study to: 1) adapt an existing CCM for rural and low-resource obstetric settings, and 2) evaluate the effects of the adapted CCM on MOUD...
This $157,684 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a study to understand inequities in harm reduction services provided to persons with opioid use disorder in hospital settings. The project aims to develop and validate a natural language processing (NLP) system to identify patterns of harm reduction language and other relevant data in electronic health record (EHR) clinical notes....
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $390,635 to the University of Pittsburgh to develop and test a novel intervention targeting prenatal depressive symptoms to encourage tobacco and cannabis cessation among marginalized pregnant and postpartum individuals. The key activities include: 1) Conducting formative research to contextualize the role of depressive symptoms in prenatal...
This $451,962 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to address racial disparities in opioid overdose deaths among Black and Latinx people who use opioids (PWUO). The project will: Adapt an evidence-supported Cultural and Structural Humility (CSH) training to an interactive video format for peer recovery coaches (PRCs) to enhance their telephone-based care coordination services for PWUO. Refine an...
The National Institute on Drug Abuse (NIDA) awarded Magee-Womens Research Institute and Foundation a $3,092,159 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to conduct a multimodal analysis of gestational health and placental injury in opioid-affected pregnancies. The goal is to investigate the direct impact of illicit and prescription opioids on placental development, differentiation, and function, focusing on the critical syncytiotrophoblast and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop efficient statistical methods for data fusion to improve the power and external validity of clinical trials for treating opioid use disorder. The $564,326 award, with a performance period from August 2024 to May 2029, will fund the development of new parametric and semiparametric estimators for average treatment effects,...
This Project Grant award, totaling $181,040.00, was issued by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award aims to create an immersive training experience for the applicant to develop a unique skillset at the intersection of psychiatric genetics, substance use disorder (SUD) epidemiology and health disparities, SUD psychopharmacology, clinical informatics, and bioinformatics. The research will leverage the Million Veteran...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $193,550 to Boston Medical Center Corporation (BMC) over a 5-year period from February 1, 2025 to January 31, 2030. The funding will support the community-engaged development and pilot testing of a peer breastfeeding support intervention for mothers with opioid use disorder (OUD). The key objectives are to: 1) engage mothers with OUD to identify...
The Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to characterize health outcomes in children born to individuals with opioid use disorder (OUD) and identify protective health system factors. The award, totaling $1,499,606.00, was granted to the Dartmouth-Hitchcock Clinic and will run from September 30, 2024 to July 31, 2029. The key objectives are to: 1) Examine variation in the diagnosis of...